ADMA News and Press, ADMA Biologics Inc From 05/10/23

2023-05-10 21:02:04 ET ADMA Biologics, Inc. (ADMA) Q1 2023 Results Conference Call May 10, 2023 04:30 PM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - President and Chief Executive Officer Bria...

2023-05-10 16:11:41 ET ADMA Biologics press release ( NASDAQ: ADMA ): Q1 GAAP EPS of -$0.03 beats by $0.01 . Revenue of $57M (+95.9% Y/Y) beats by $3.59M . 2023 Financial Guidance: ADMA now anticipates full year 2023 total revenues to exceed $220 million, ...

1Q2023 Total Revenues of $57 Million, a 96% Y-o-Y Increase 1Q2023 Net Loss of $6.8 Million, a 73% Y-o-Y Improvement Achieved Milestone First-Time Positive Adjusted EBITDA (1 ) , Totaling $2.5 Million, Earlier Than Forecasted FY2023 Total Revenue Now E...

2023-05-09 17:35:54 ET ADMA Biologics ( NASDAQ: ADMA ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.04 and the consensus Revenue Estimate is $53.41M (+83.5% Y/Y). Over the last 1 year, ADMA ...

RAMSEY, N.J. and BOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologic...

2023-05-02 10:49:54 ET ADMA Biologics ( NASDAQ: ADMA ) has amended the terms of its existing senior credit facility with Hayfin Capital Management, which matures in March 2027. “This credit agreement amendment with Hayfin enhances the Company’s already stron...

Reduces Nominal Interest Rate by 1% Provides for Improved Prepayment Flexibility Total Debt Level Unchanged Favorable Amendment Enabled by Strengthened Financial Outlook RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasda...

2023-04-06 17:02:48 ET Gainers: Ramaco Resources ( METC ) +5% . Aemetis ( AMTX ) +5% . El Pollo Loco Holdings ( LOCO ) +5% . Independent Bank Corporation ( IBCP ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: Nurix Th...

2023-03-29 15:52:09 ET Summary ADMA Biologics, Inc. recently reported their Q4 and Full-Year 2022 earnings, which revealed a beat on EPS and revenue. The company believes 2023 will be a significant “inflection point.”. The company is establishing strong growth trends...

2023-03-23 22:10:03 ET ADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Conference Call March 23, 2023, 16:30 ET Company Participants Skyler Bloom - Senior Director of Business Development & Corporate Strategy Adam Grossman - Co-Founder, President, CEO & Director...